Drug · DIN 02437643
PROPOFOL INJECTION
FOR I.V. INFUSION. 200 MG/20 ML, 500 MG/50 ML, AND 1000 MG/100 ML SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 1, 2015; first marketed June 1, 2015.
- Drug Identification Number (DIN)
- 02437643
- Company (DIN owner)
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Emulsion
- Route
- Intravenous
- Therapeutic class (ATC)
- Propofol N01AX10
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROPOFOL | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 23, 2015: NOC 16632Abbreviated New Drug Submission (ANDS)
Other DINs named PROPOFOL INJECTION
- DIN 02244379 · Marketed
- DIN 02525879 · Marketed
- DIN 02236887 · Cancelled Post Market
- DIN 02241504 · Cancelled Post Market
- DIN 02242973 · Cancelled Post Market
- DIN 02559692 · Approved